Fifth Third Bancorp’s Inhibrx INBX Stock Holding History

Fifth Third Bancorp’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99K	Hold	21	–	–	﹤0.01%	4088
2026 Q1	$1.41K	Buy	+21	New	+$1.56K	﹤0.01%	4091

Other funds holding INBX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fifth Third Bancorp's INBX Position: Q2 2026 in Review

Fifth Third Bancorp held its Inhibrx (INBX) position steady in Q2 2026 at 21 shares worth $1.99K. The position accounts for ﹤0.01% of the portfolio, ranked #4088.

Fifth Third Bancorp first reported a position in INBX in Q1 2026 and has held it in 2 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

Fifth Third Bancorp held 21 shares of Inhibrx worth $1.99K as of Q2 2026.
Fifth Third Bancorp left its Inhibrx share count unchanged in Q2 2026.
Inhibrx made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4088 holding.
Fifth Third Bancorp first reported a position in Inhibrx in Q1 2026 and has held it in 2 quarters since.
163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.